SLU Study: Immune Dysfunction Increases Cancer Risk in Obese Populations
11/14/2024
ST. LOUIS —Researchers at Saint Louis University’s School of Medicine say T-cell dysfunction is leading to an increased risk of cancer in obese populations.
T cells are white blood cells called lymphocytes essential to your immune system in the fight against infections and cancer. Ryan Teague, Ph.D., professor of molecular microbiology and immunology at SLU, and his team are exploring why obesity impacts T-cell dysfunction and compromises immune surveillance, or the body’s ability to survey malignant cells and clear them before they become tumors.
Ryan Teague, Ph.D., left, and Alex Piening, an M.D./Ph.D. graduate student at SLU, work in the lab in Doisy Research Center on October 21, 2024. Photo by Sarah Conroy.
The study, which was led by Teague and co-authored by Alex Piening, an M.D./Ph.D. graduate student at SLU, was recently published in Nature Communications, found that T-cell dysfunction linked to obesity prevented T cells from detecting tumor cells, placing obese mice at higher risk of developing tumors when exposed to a carcinogen. Teague and his team are now trying to uncover the exact mechanism underlying the metabolic dysfunctions associated with obesity that directly impact T-cell function.
Ongoing projects in Teague’s lab at SLU are designed to identify barriers to successful cancer immunotherapy and develop strategies to overcome these barriers for improved patient outcomes. Teague and his team investigate how obesity impacts the efficacy of immunotherapies.
"Immunotherapy boosts a patient's immune system by targeting T cells and reinvigorating them. Paradoxically, immunotherapy is often more successful in patients with obesity, where the immune system isn’t functioning quite as well," Teague said. "Our research explains this paradox by showing that in the setting of obesity, developing tumors are only required to escape a weakened immune system. Such outgrown tumors are not well adapted to evade the reinvigorated T cells elicited during immunotherapy, and thus, are more easily destroyed."
Teague said single-cell RNA sequencing played a critical role in the study’s findings, which allowed scientists to learn what’s happening inside individual immune cells within tumors.
"We learned that the dysfunction in these T cells lies in their inability to kill tumors. Those genes were not being turned on. It also lies in their inability to acquire the metabolic functions needed to sustain anti-tumor activity," Teague said.
Thanks to SLU’s investment in single-cell RNA sequencing technology, the Department of Molecular Microbiology and Immunology has leveraged this new approach to advance its work studying cancer and the immune system, bringing us closer to new cures.
Other authors include Kelly D. Pyles, Kyle S. McCommis, Ph.D., Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine; Emily Ebert, Carter Gottlieb, Niloufar Khojandi, Lindsey M. Kuehm, Stella G. Hoft, Richard J. DiPaolo, Ph.D., Stephen T. Ferris, Ph.D., Elise Alspach, Ph.D., Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine.
Latest Newslink
- SLU Hispanic Studies Professor Named Distinguished Visiting Professor in the Humanities at East Carolina UniversityAmy E. Wright, Ph.D., professor of Hispanic Studies at Saint Louis University, has been named the David Julian and Virginia Suther Whichard Distinguished Professor in the Humanities at East Carolina University. She will hold the visiting Whichard professorship in ECU’s Thomas Harriot College of Arts and Sciences for two years before returning to SLU.
- SLU, Maryville Team Up with Women in Cybersecurity to Close the Cyber Talent GapStudents from the Saint Louis University and Maryville University Women in Cybersecurity chapters are teaming up to address one of the nation's most critical challenges: the shortage of skilled professionals trained to combat escalating cybersecurity threats.
- SLU's Emerson Leadership Institute to Kick Off Speaker Series with Barry-Wehmiller's Bob ChapmanSaint Louis University’s Emerson Leadership Institute will host Bob Chapman, chairman of Barry-Wehmiller, as part of its Leadership Speaker Series on Monday, Nov. 3. The free event will include a fireside chat on dignity-based leadership with Jackson Nickerson, Ph.D., Edward Jones Dean of the Richard A. Chaifetz School of Business at SLU.
- SLU's Flying Billikens to Host Regional Event for National Intercollegiate Flying CompetitionThe Flying Billikens from the Oliver L. Parks Department of Aviation Science will host the 2025 National Intercollegiate Flying Association Competition's Region VI and VIII SAFECON event Oct. 13-18 at the St. Louis Downtown Airport.
- SLU Program in Physical Therapy Class of 2028 Celebrates White Coat CeremonyThe Saint Louis University Doctor of Physical Therapy (DPT) Class of 2028 recently celebrated its initiation into the professional phase of the program by hosting a white coat ceremony. The ceremony took place at Saint Francis Xavier College Church and celebrated more than 80 students advancing to the professional phase of the program.
- Saint Louis University Commits up to $1.4 Million for Teacher Education Through New StayTeachLead Scholarship ProgramThis week, Saint Louis University School of Education launched the StayTeachLead Scholarship Program, an initiative designed to strengthen the local teacher pipeline through direct partnerships with St. Louis area schools.
